JP Morgan Chase
EDIT icon

JP Morgan Chase’s Editas Medicine EDIT Stock Holding History

JP Morgan Chase’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-217,500
Closed -$6.32M – 5699
2020
Q3 		$6.32M Sell
217,500
-24,500
-10% -$798K ﹤0.01% 2371
2020
Q2 		$7.16M Sell
242,000
-73,800
-23% -$1.93M ﹤0.01% 2171
2020
Q1 		$6.26M Buy
315,800
+70,000
+28% +$1.77M ﹤0.01% 2080
2019
Q4 		$7.28M Buy
+245,800
New +$6.14M ﹤0.01% 2387
2019
Q1 		– Sell
-395,000
Closed -$8.99M – 5826
2018
Q4 		$8.99M Buy
395,000
+121,800
+45% +$3.31M ﹤0.01% 2104
2018
Q3 		$8.69M Sell
273,200
-156,400
-36% -$5.05M ﹤0.01% 2313
2018
Q2 		$15.4M Buy
429,600
+349,600
+437% +$12.4M ﹤0.01% 1800
2018
Q1 		$2.65M Buy
80,000
+40,000
+100% +$1.43M ﹤0.01% 3067
2017
Q4 		$1.23M Buy
+40,000
New +$1.01M ﹤0.01% 3601

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

JP Morgan Chase's EDIT Position: Q2 2026 in Review

JP Morgan Chase reduced its Editas Medicine (EDIT) stake by 4.4% in Q2 2026, selling an estimated $248K and leaving 1,862,494 shares worth $5.96M. The position accounts for ﹤0.01% of the portfolio, ranked #3294.

JP Morgan Chase first reported a position in EDIT in Q1 2016 and has held it in 40 quarters since. The position peaked at $62.4M in Q2 2021. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • JP Morgan Chase held 1,862,494 shares of Editas Medicine worth $5.96M as of Q2 2026.
  • JP Morgan Chase sold 84,890 Editas Medicine shares in Q2 2026, an estimated $248K.
  • Editas Medicine made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3294 holding.
  • JP Morgan Chase first reported a position in Editas Medicine in Q1 2016 and has held it in 40 quarters since.
  • JP Morgan Chase's Editas Medicine position peaked at $62.4M in Q2 2021.
  • 216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.